Tsai, Meng-Hua M.
National Institutes of Health · National Institute on Drug Abuse
4 papers on CoChatORCID 0000-0002-5161-9909
Most cited papers
- Verified
Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose
Glatfelter, G. C., Vandeputte, M. M., Chen, L., Walther, D., Tsai, M.-H. M., Shi, L., Stove, C. P., & Baumann, M. H. (2023) · Psychopharmacology
Forensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment
Cited by 52
- Verified
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Vandeputte, M. M., Tsai, M.-H. M., Chen, L., Glatfelter, G. C., Walther, D., Stove, C. P., Shi, L., & Baumann, M. H. (2023) · Drug and Alcohol Dependence
Opioid Use Disorder TreatmentForensic Toxicology and Drug Analysis
Cited by 39
- Verified
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling
Tsai, M.-H. M., Chen, L., Baumann, M. H., Canals, M., Javitch, J. A., Lane, J. R., & Shi, L. (2024) · ACS Chemical Neuroscience
Receptor Mechanisms and SignalingNeuropeptides and Animal Physiology
Cited by 27
- Verified
Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl
Xie, B., Le Rouzic, V. P., Goldberg, A., Tsai, M.-H. M., Chen, L., Zhang, T., Sinha, A., Pan, Y.-X., Baumann, M. H., & Shi, L. (2023) · Neuropharmacology
Receptor Mechanisms and SignalingOpioid Use Disorder Treatment
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free